1,2 OPM2 and U266 cells were transfected with luciferase (OPM2-Lu/U266-Lu) as previously described. 3 Informed consent was obtained from subjects according to the Declaration of Helsinki. The University of Arkansas for Medical Sciences Institutional Review Board approved this study. CD138 + multiple myeloma (MM) and CD34 + progenitor cells were isolated from bone marrow or apheresis products, respectively, using magnetic bead selection following the manufacturer's instructions (Miltenyi Biotech, Auburn, CA, USA). For gene expression profiling (GEP), non-expanded (non-exp-) and expanded natural killer (exp-NK) cells were purified using the EasySep kit according to the manufacturer's instructions (StemCell Technologies, Vancouver, Canada) resulting in >95% CD56 + /CD3 -NK cells. Prior to injection into mice exp-NK cells were >95% CD56 + CD3 -. Patients' phytohemagglutinin-blast cells were generated by stimulating peripheral blood mononuclear cells with 2 μg/mL phytohemagglutinin and 50 IU/mL interleukin (IL)2 for 1 week.
Natural killer cell expansion
Peripheral blood was centrifuged over Ficoll-Paque PLUS (Amersham Biosciences, Piscataway, NJ, USA). Peripheral blood mononuclear cells were harvested and washed in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS) (Invitrogen). The peripheral blood mononuclear cells were then co-cultured with irradiated (100 Gray) K562-mb15-41BBL cells at a ratio of 1.5:1 in RPMI 1640 + 10% FBS + 300 IU/mL IL2 (Prometheus, San Diego, CA, USA). One half of the medium was changed every other day with fresh medium containing IL2. The NK cells were re-stimulated with K562-mb15-41BBL cells on day 7 and collected on days 10-14 for assays. The number of viable cells was based on counts using trypan blue exclusion. Fold expansion was calculated by dividing the number of viable cells at day 7 or day 10-14 by the number of cells at the beginning of the culture (day 0).
Gene expression profiling
Purified non-exp-NK cells and exp-NK cells from healthy donors (HD) and MM patients were subjected to GEP, performed with the Affymetrix U133 Plus 2.0 microarray platform (Santa Clara, CA, USA). 4, 5 Microarray data have been deposited in the NIH Gene Expression Omnibus available at http//www.ncbi.nlm.nih.gov/geo under accession number GSE27838. Gene expression data were normalized with MAS5 using default parameters in Affymetrix GeneChip operating software. All statistical analyses were performed with the statistics software R (Version 2.12.0; available from http://www.rproject.org) and R packages developed by the BioConductor project (available from http://www.bioconductor.org). The reported fold change was defined as the ratio of geometric means of expression data for exp-NK cells versus non-exp-NK cells or MM NK values versus HD NK values. The paired t test and independent two-sample t test were used on log-transformed GEP intensity values for exp-NK versus non-exp-NK comparisons and MM versus HD comparisons, respectively. The Q-value 6 was used to estimate the false discovery rate and identify differentially expressed genes. The false discovery rate cutoff was set at < 0.05.
51
Cr release cytotoxicity assays Target cells were incubated for 1.5 h with 100 μCi sodium chromate 51 (PerkinElmer Inc., Billerica, MA, USA), washed, and then incubated with effectors at the indicated E:T ratios in RPMI 1640 media + 10% FBS in 96-well V-bottom plates. Effector cells were whole NK cell cultures since there was little contamination by NKT cells, T-cells and γδ T-cells. After incubation for 4 h, supernatants were collected to determine target cell lysis. Controls for spontaneous release and maximum release were included in replicates of six while each E:T ratio was performed in triplicate. Specific lysis percentage was calculated as [(test release -spontaneous release)/(maximal releasespontaneous release) x 100].
Time-lapse microscopy
K562-mb15-41BBL cells with high expression of enhanced green fluorescence protein (GFP) or primary MM cells were seeded in poly-l-lysine coated glass bottom Petri dishes (MatTek Corp., Ashland, MA, USA). For time-lapse microscopy, Petri dishes were placed on a temperature controlled stage with a 5% CO2 chamber fitted with a Zeiss Axiovert 100M inverted microscope (Carl Zeiss, Germany). Patients' exp-NK cells were introduced into the dish prior to imaging with a 2:1 E:T ratio. Images were collected with a Zeiss 20X differential interference contrast (DIC) objective, using 520/18 excitation, 565/20 emission, 545DRLP dichroic and XF203 filter set, every 12 sec for 120 min using a Scion CG-7 frame grabber (Scion Corp., Frederick, MD, USA). The images were processed with Image J software (NIH, Bethesda, MD, USA).
Cytokine analysis by cytometric bead array
In vitro cytokine secretion of exp-NK cells was assessed by culturing 1x10 5 purified NK cells and 5x10 4 K562 cells in a 96-well U-bottom tissue culture plate (BD Falcon) in 200 μL of medium for 72 h. The supernatant content of tumor necrosis factor-a, interferon-γ, IL4, IL6 and IL10 was assayed using a cytometric bead array according to the manufacturer's protocol (BD Biosciences Pharmingen, San Diego, CA, USA).
Murine model
For live-animal imaging, mice were anesthetized with ketamine plus xylazine and injected intraperitoneally with Dluciferin firefly potassium salt (150 mg/kg; Caliper Life Sciences, Hopkinton, MA, USA). Luciferase activity was detected using the Xenogen IVIS 200 imaging system (Caliper Life Sciences). For enzyme-linked immunosorbent assays (ELISA), mice were bled from the tail weekly to obtain 100 μL of blood in EDTA-coated tubes. The specimens were spun for 20 min and both plasma and cellular fractions were harvested. We have validated the use of murine plasma for human immunoglobulin ELISA, performed as previously described. 7, 8 The peripheral blood cellular fraction was then used for flow cytometry determination of persistence, phenotyping and in vivo expansion assays.
Histology and immunohistochemistry
All reactions were performed using an automated immunostainer (DakoCytomation, Carpenteria, CA, USA) in conjunction with the Envision TM -HRP or -AP detection systems (Dako Cytomation) using either diaminobenzidine or Fast Red as the chromogens for dual staining. Endogenous peroxidase was inhibited with methyl alcohol containing 0.01% H2O2 with additional blocking carried out using Background Sniper TM (Biocare Medical, Concord, CA, USA) and/or Background Terminator TM (Biocare Medical). Nuclei were counterstained with hematoxylin and sections were evaluated by light microscopy using an Olympus BH-2 microscope (Olympus, Melville, NY, USA) fitted with a SPOT2 digital camera (Diagnostic Instruments, Sterling Heights, MI, USA).
